Session R.A. II

Track

Insider profile

Performance

Overall performance
1.2
Performance over holding periods
4.2
30 days 90 days 120 days
Average return 2% 8.2% 15.1%
Success rate 93% 68% 82%
Transactions
8 25% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return -94%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance
Session R.A. II's trades of Taysha Gene Therapies Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Price
110.32
Quantity 3,969 +46.0%
Value US$1,242,836
Transaction date
Proposed sale
Price
0.70
Quantity 1,006,000
Value US$699,572
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-07-14 2023-07-13
S Sale
3,969 +46.0%
110.32
US$1,242,836 		3,969 +46.0% 110.32 US$1,242,836
2023-07-14 2023-07-12
S Sale
36,851 +18.3%
499.93
US$2,834,980 		36,851 +18.3% 499.93 US$2,834,980
2023-06-26 2023-06-23
S Sale
84,415 -12.1%
127.60
US$366,054 		84,415 -12.1% 127.60 US$366,054
2023-06-26 2023-06-22
S Sale
10,508 -0.1%
0.70
US$7,384 		10,508 -0.1% 0.70 US$7,384
2023-06-22 2023-06-21
S Sale
138,962 -1.5%
0.70
US$97,635 		138,962 -1.5% 0.70 US$97,635
2023-06-22 2023-06-20
S Sale
295,653 -3.1%
0.71
US$210,209 		295,653 -3.1% 0.71 US$210,209
2023-06-20 2023-06-20
PrS Proposed sale
1,006,000
0.70
US$699,572 		1,006,000 0.70 US$699,572
2023-06-20 2023-06-20
PrS Proposed sale
1,006,000
0.70
US$699,572 		1,006,000 0.70 US$699,572
2021-12-08 2021-11-23
B Purchase
26,008 +0.3%
12.65
US$329,001 		26,008 +0.3% 12.65 US$329,001
2021-12-08 2021-11-23
B Purchase
16,510 +0.2%
12.12
US$200,101 		16,510 +0.2% 12.12 US$200,101